Combination Therapy for Overactive Bladder: Should We Define Refractoriness?
Saved in:
| Published in: | European urology Vol. 76; no. 6; pp. 780 - 781 |
|---|---|
| Main Authors: | , |
| Format: | Journal Article |
| Language: | English |
| Published: |
Elsevier B.V
01-12-2019
|
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Author | Padilla-Fernández, Bárbara Castro-Díaz, David M. |
|---|---|
| Author_xml | – sequence: 1 givenname: Bárbara surname: Padilla-Fernández fullname: Padilla-Fernández, Bárbara email: padillaf83@hotmail.com – sequence: 2 givenname: David M. surname: Castro-Díaz fullname: Castro-Díaz, David M. |
| BookMark | eNp9kE1LAzEQhoMo2Fb_gYc9etk6SfbTg6L1EwoFrXgM2dkJTdluarJb6L93Sz0LL8wMPPMO847ZaetaYuyKw5QDz27WU-p9791UAC-nMAjkCRvxIpdxnmZwykYgQcSikMU5G4ewhoFISzli85nbVLbVnXVttFyR19t9ZJyPFruhx87uKHpsdF2Tv40-V65v6uiboicytqXog8wBcn4YQri_YGdGN4Eu_-qEfb08L2dv8Xzx-j57mMcoZdnFyFNCWdUC0qwSMqlkhZlMEy0KRI4ARAYxwzJPtBZYSQ7SZKWgKktqY6ScsOuj79a7n55CpzY2IDWNbsn1QQlRpkmR8xwGNDmi6F0InozaervRfq84qEN4aq2O4alDeAoGweHC3XGNhjd2lrwKaKlFqq0n7FTt7P8Gv8MWfM0 |
| CitedBy_id | crossref_primary_10_1007_s00192_023_05704_0 crossref_primary_10_1007_s00192_023_05517_1 |
| Cites_doi | 10.1016/j.eururo.2016.02.063 10.1097/JU.0000000000000309 10.1002/nau.22512 10.1007/s00192-015-2674-0 10.1016/j.eururo.2019.07.010 10.1007/s00192-014-2462-2 10.1185/03007995.2013.860021 |
| ContentType | Journal Article |
| Copyright | 2019 European Association of Urology |
| Copyright_xml | – notice: 2019 European Association of Urology |
| DBID | AAYXX CITATION 7X8 |
| DOI | 10.1016/j.eururo.2019.09.003 |
| DatabaseName | CrossRef MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE - Academic |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1873-7560 |
| EndPage | 781 |
| ExternalDocumentID | 10_1016_j_eururo_2019_09_003 S030228381930692X |
| Genre | Commentary Editorial |
| GroupedDBID | --- --K --M .1- .55 .FO .GJ .~1 0R~ 0~B 1B1 1P~ 1~. 1~5 29G 30W 34G 39C 4.4 457 4G. 53G 5GY 5RE 5VS 7-5 71M 8P~ 8UI AABNK AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAXUO AAYIC ABBQC ABFNM ABJNI ABLJU ABLVK ABMAC ABMZM ABOCM ABXDB ABYKQ ACDAQ ACRLP ADBBV ADEZE ADMUD AEBSH AEKER AENEX AEVXI AEYAO AFCTW AFKWA AFRHN AFTJW AFXIZ AGHFR AGUBO AGYEJ AHPSJ AIEXJ AIKHN AITUG AJBFU AJOXV AJRQY AJUYK ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX AXJTR AZPMC BKOJK BLXMC BNPGV CAG COF CS3 CYUIP DU5 E0A EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 F5P FB. FDB FEDTE FIRID FNPLU FYGXN G-Q GBLVA HVGLF HZ~ IHE J1W KOM LCYCR M41 MO0 N9A O-L O1H O9- OAUVE OK. OW. OZT P-8 P-9 P2P PC. Q38 RIG RKO ROL RPZ SCC SDF SDG SEL SES SEW SPCBC SSH SSZ T5K UDS UJ6 UV1 X7M Z5R ZA5 ZGI ZXP ~G- AAXKI AAYXX AFJKZ AKRWK CITATION 7X8 |
| ID | FETCH-LOGICAL-c339t-c15ec3bd2056b234b3bc6354a28cc1c00eefcc6c974aa2cb3103f692eb64dff33 |
| ISSN | 0302-2838 |
| IngestDate | Fri Oct 25 05:39:50 EDT 2024 Thu Sep 26 18:50:03 EDT 2024 Fri Feb 23 02:48:22 EST 2024 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 6 |
| Language | English |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c339t-c15ec3bd2056b234b3bc6354a28cc1c00eefcc6c974aa2cb3103f692eb64dff33 |
| Notes | SourceType-Other Sources-1 content type line 63 ObjectType-Editorial-2 ObjectType-Commentary-1 |
| PQID | 2295487170 |
| PQPubID | 23479 |
| PageCount | 2 |
| ParticipantIDs | proquest_miscellaneous_2295487170 crossref_primary_10_1016_j_eururo_2019_09_003 elsevier_sciencedirect_doi_10_1016_j_eururo_2019_09_003 |
| PublicationCentury | 2000 |
| PublicationDate | December 2019 2019-12-00 20191201 |
| PublicationDateYYYYMMDD | 2019-12-01 |
| PublicationDate_xml | – month: 12 year: 2019 text: December 2019 |
| PublicationDecade | 2010 |
| PublicationTitle | European urology |
| PublicationYear | 2019 |
| Publisher | Elsevier B.V |
| Publisher_xml | – name: Elsevier B.V |
| References | Burkhard, Bosch, Cruz (bib0005) 2019 Goldman, Wyndaele, Kaplan, Wang, Ntanios (bib0035) 2014; 30 National Institute for Health and Care Excellence (bib0030) 2013 Balachandran, Curtiss, Basu, Duckett (bib0045) 2015; 26 Gratzke, Chapple, Mueller (bib0015) 2019; 76 Padilla-Fernández, Castro-Díaz (bib0020) 2016; 70 Lightner, Gomelsky, Souter, Vasavada (bib0025) 2019; 202 Phé, de Wachter, Rouprêt, Chartier-Kastler (bib0040) 2015; 34 National Institute for Health and Care Excellence (bib0010) 2019 Schwantes, Grosse, Wiedemann (bib0050) 2015; 26 National Institute for Health and Care Excellence (10.1016/j.eururo.2019.09.003_bib0030) 2013 Goldman (10.1016/j.eururo.2019.09.003_bib0035) 2014; 30 Burkhard (10.1016/j.eururo.2019.09.003_bib0005) 2019 Phé (10.1016/j.eururo.2019.09.003_bib0040) 2015; 34 National Institute for Health and Care Excellence (10.1016/j.eururo.2019.09.003_bib0010) 2019 Padilla-Fernández (10.1016/j.eururo.2019.09.003_bib0020) 2016; 70 Gratzke (10.1016/j.eururo.2019.09.003_bib0015) 2019; 76 Balachandran (10.1016/j.eururo.2019.09.003_bib0045) 2015; 26 Schwantes (10.1016/j.eururo.2019.09.003_bib0050) 2015; 26 Lightner (10.1016/j.eururo.2019.09.003_bib0025) 2019; 202 |
| References_xml | – volume: 70 start-page: 146 year: 2016 end-page: 147 ident: bib0020 article-title: Is combination better than escalation for overactive bladder therapy? publication-title: Eur Urol contributor: fullname: Castro-Díaz – volume: 76 start-page: 767 year: 2019 end-page: 779 ident: bib0015 article-title: Efficacy and safety of combination pharmacotherapy for patients with overactive bladder: a rapid evidence assessment publication-title: Eur Urol contributor: fullname: Mueller – volume: 26 start-page: 367 year: 2015 end-page: 372 ident: bib0045 article-title: Third-line treatment for overactive bladder: should mirabegron be tried before intravesical botulinum toxin A therapy? publication-title: Int Urogynecol J contributor: fullname: Duckett – volume: 202 start-page: 558 year: 2019 end-page: 563 ident: bib0025 article-title: Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline amendment 2019 publication-title: J Urol contributor: fullname: Vasavada – year: 2019 ident: bib0005 article-title: EAU guidelines on urinary incontinence contributor: fullname: Cruz – volume: 30 start-page: 509 year: 2014 end-page: 526 ident: bib0035 article-title: Defining response and non-response to treatment in patients with overactive bladder: a systematic review publication-title: Curr Med Res Opin contributor: fullname: Ntanios – year: 2019 ident: bib0010 article-title: Urinary incontinence and pelvic organ prolapse in women: management. NICE guideline NG123 contributor: fullname: National Institute for Health and Care Excellence – year: 2013 ident: bib0030 article-title: Mirabegron for treating symptoms of overactive bladder. Technology appraisal guidance TA290 contributor: fullname: National Institute for Health and Care Excellence – volume: 34 start-page: 2 year: 2015 end-page: 11 ident: bib0040 article-title: How to define a refractory idiopathic overactive bladder? publication-title: Neurourol Urodyn contributor: fullname: Chartier-Kastler – volume: 26 start-page: 1407 year: 2015 end-page: 1414 ident: bib0050 article-title: Refractory overactive bladder: a common problem? publication-title: Int Urogynecol J contributor: fullname: Wiedemann – volume: 70 start-page: 146 year: 2016 ident: 10.1016/j.eururo.2019.09.003_bib0020 article-title: Is combination better than escalation for overactive bladder therapy? publication-title: Eur Urol doi: 10.1016/j.eururo.2016.02.063 contributor: fullname: Padilla-Fernández – year: 2019 ident: 10.1016/j.eururo.2019.09.003_bib0005 contributor: fullname: Burkhard – year: 2019 ident: 10.1016/j.eururo.2019.09.003_bib0010 contributor: fullname: National Institute for Health and Care Excellence – volume: 202 start-page: 558 year: 2019 ident: 10.1016/j.eururo.2019.09.003_bib0025 article-title: Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline amendment 2019 publication-title: J Urol doi: 10.1097/JU.0000000000000309 contributor: fullname: Lightner – volume: 34 start-page: 2 year: 2015 ident: 10.1016/j.eururo.2019.09.003_bib0040 article-title: How to define a refractory idiopathic overactive bladder? publication-title: Neurourol Urodyn doi: 10.1002/nau.22512 contributor: fullname: Phé – volume: 26 start-page: 1407 year: 2015 ident: 10.1016/j.eururo.2019.09.003_bib0050 article-title: Refractory overactive bladder: a common problem? publication-title: Int Urogynecol J doi: 10.1007/s00192-015-2674-0 contributor: fullname: Schwantes – volume: 76 start-page: 767 year: 2019 ident: 10.1016/j.eururo.2019.09.003_bib0015 article-title: Efficacy and safety of combination pharmacotherapy for patients with overactive bladder: a rapid evidence assessment publication-title: Eur Urol doi: 10.1016/j.eururo.2019.07.010 contributor: fullname: Gratzke – volume: 26 start-page: 367 year: 2015 ident: 10.1016/j.eururo.2019.09.003_bib0045 article-title: Third-line treatment for overactive bladder: should mirabegron be tried before intravesical botulinum toxin A therapy? publication-title: Int Urogynecol J doi: 10.1007/s00192-014-2462-2 contributor: fullname: Balachandran – volume: 30 start-page: 509 year: 2014 ident: 10.1016/j.eururo.2019.09.003_bib0035 article-title: Defining response and non-response to treatment in patients with overactive bladder: a systematic review publication-title: Curr Med Res Opin doi: 10.1185/03007995.2013.860021 contributor: fullname: Goldman – year: 2013 ident: 10.1016/j.eururo.2019.09.003_bib0030 contributor: fullname: National Institute for Health and Care Excellence |
| SSID | ssj0003593 |
| Score | 2.3693435 |
| SourceID | proquest crossref elsevier |
| SourceType | Aggregation Database Publisher |
| StartPage | 780 |
| Title | Combination Therapy for Overactive Bladder: Should We Define Refractoriness? |
| URI | https://dx.doi.org/10.1016/j.eururo.2019.09.003 https://search.proquest.com/docview/2295487170 |
| Volume | 76 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LaxsxEBZOCqWX0CdN-kCF3ozCrrS78vZSktolh6YtsUtCL0KrlQih2MWPS359Z_RYuzalD-hlbcteeXfm29Fo9GmGkNeu4rzNnWOZsxUryhqeOZ5rZrM2l65seePJmGdj-fFqMBwVo17vNs36u7b_qmloA13jztm_0HbXKTTAe9A5HEHrcPwjvcMDDpPdoNZJSBngqYSf4E60N27902_a5w0RJ_3xNZa47l8ie8ihw3lh3dyX4PF0-G3aXwrdw-tmNP6zbrF4EcOgtF95z1Nk-jR89Gsa6-WOxXI-Y0P_1VDfdtT6_vnxZhAir7cIHbu7Y8KOLL_1O2RvObbBwA6kYLIMNQSSBQ4VYCLSNs2pDFWe4sgsQ3GXHaMf4g83mCkTbh_perXPXZuJ9SDXUQ_HeFV4UeC5ZlXNr_bIHQ5GCm3k1_KiG8VFTNic7iFtu_TcwN1_-pVbszXAe69lcp8cxOkGPQk4eUB6dvqQ3D2PhIpH5MMGXGiECwW40DVcaITLGxrAQi8tDWChP4Pl7WPy5f1o8u6MxQIbzAhRL5nJS2tE03LwghsuikY0BhzQQvOBMbnJMmudMZWBOafW3DRYk86BzGxTFa1zQjwh-9PZ1D4lFDrCNWT4kXFF2cqBrjQvGhCjKw04nYeEJfmo7yGPikoEwxsV5KlQniqrMV_tIZFJiCr6gsHHU6D135z5KslcganE9S89tbPVQmHlepif5zI7-ufen5F7a_w_J_vL-cq-IHuLdvXS4-cHDkuL8g |
| link.rule.ids | 315,782,786,27933,27934 |
| linkProvider | Elsevier |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Combination+Therapy+for+Overactive+Bladder%3A+Should+We+Define+Refractoriness%3F&rft.jtitle=European+urology&rft.au=Padilla-Fern%C3%A1ndez%2C+B%C3%A1rbara&rft.au=Castro-D%C3%ADaz%2C+David+M.&rft.date=2019-12-01&rft.pub=Elsevier+B.V&rft.issn=0302-2838&rft.eissn=1873-7560&rft.volume=76&rft.issue=6&rft.spage=780&rft.epage=781&rft_id=info:doi/10.1016%2Fj.eururo.2019.09.003&rft.externalDocID=S030228381930692X |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0302-2838&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0302-2838&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0302-2838&client=summon |